Devika Unnithan

3 weeks ago | tandfonline.com | Devika Unnithan |Aysha Khan |Javed Ali |Mohammad Khan

ABSTRACTIntroduction Alzheimer’s Disease (AD) is a progressive neurological disordermarked by cognitive decline and memory loss. Current treatments,including acetylcholinesterase inhibitors (AChEIs) and NMDA receptorantagonists, provide only symptomatic relief due to poor Blood BrainBarrier (BBB) permeability and side effects. The integration ofsynthetic and natural drug combinations with nanotechnology offers apromising strategy to enhance drug delivery, efficacy, and overalltherapeutic outcomes.